Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K
Department of Neurochemistry and Neuropharmacology, Biomedical Research Center, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
J Cell Biol. 1999 May 17;145(4):727-40. doi: 10.1083/jcb.145.4.727.
The molecular mechanisms behind phenotypic modulation of smooth muscle cells (SMCs) remain unclear. In our recent paper, we reported the establishment of novel culture system of gizzard SMCs (Hayashi, K., H. Saga, Y. Chimori, K. Kimura, Y. Yamanaka, and K. Sobue. 1998. J. Biol. Chem. 273: 28860-28867), in which insulin-like growth factor-I (IGF-I) was the most potent for maintaining the differentiated SMC phenotype, and IGF-I triggered the phosphoinositide 3-kinase (PI3-K) and protein kinase B (PKB(Akt)) pathway. Here, we investigated the signaling pathways involved in de-differentiation of gizzard SMCs induced by PDGF-BB, bFGF, and EGF. In contrast to the IGF-I-triggered pathway, PDGF-BB, bFGF, and EGF coordinately activated ERK and p38MAPK pathways. Further, the forced expression of active forms of MEK1 and MKK6, which are the upstream kinases of ERK and p38MAPK, respectively, induced de-differentiation even when SMCs were stimulated with IGF-I. Among three growth factors, PDGF-BB only triggered the PI3-K/PKB(Akt) pathway in addition to the ERK and p38MAPK pathways. When the ERK and p38MAPK pathways were simultaneously blocked by their specific inhibitors or an active form of either PI3-K or PKB(Akt) was transfected, PDGF-BB in turn initiated to maintain the differentiated SMC phenotype. We applied these findings to vascular SMCs, and demonstrated the possibility that the same signaling pathways might be involved in regulating the vascular SMC phenotype. These results suggest that changes in the balance between the PI3-K/PKB(Akt) pathway and the ERK and p38MAPK pathways would determine phenotypes of visceral and vascular SMCs. We further reported that SMCs cotransfected with active forms of MEK1 and MKK6 secreted a nondialyzable, heat-labile protein factor(s) which induced de-differentiation of surrounding normal SMCs.
平滑肌细胞(SMCs)表型调节背后的分子机制仍不清楚。在我们最近的论文中,我们报道了建立了新颖的砂囊SMCs培养系统(林,K.,佐贺,H.,千森,Y.,木村,K.,山中,Y.,和矶部,K. 1998. J.生物化学. 273: 28860 - 28867),其中胰岛素样生长因子-I(IGF-I)对维持分化的SMCs表型最有效,并且IGF-I触发了磷酸肌醇3-激酶(PI3-K)和蛋白激酶B(PKB(Akt))途径。在此,我们研究了由血小板衍生生长因子-BB(PDGF-BB)、碱性成纤维细胞生长因子(bFGF)和表皮生长因子(EGF)诱导的砂囊SMCs去分化所涉及的信号通路。与IGF-I触发的途径相反,PDGF-BB、bFGF和EGF协同激活细胞外信号调节激酶(ERK)和p38丝裂原活化蛋白激酶(p38MAPK)途径。此外,分别作为ERK和p38MAPK上游激酶的MEK1和MKK6活性形式的强制表达,即使在SMCs用IGF-I刺激时也诱导去分化。在三种生长因子中,PDGF-BB除了ERK和p38MAPK途径外,还仅触发PI3-K/PKB(Akt)途径。当ERK和p38MAPK途径被其特异性抑制剂同时阻断或转染PI3-K或PKB(Akt)的活性形式时,PDGF-BB转而开始维持分化的SMCs表型。我们将这些发现应用于血管SMCs,并证明了相同的信号通路可能参与调节血管SMCs表型的可能性。这些结果表明,PI3-K/PKB(Akt)途径与ERK和p38MAPK途径之间平衡的变化将决定内脏和血管SMCs的表型。我们进一步报道,用MEK1和MKK6活性形式共转染的SMCs分泌一种不可透析的、热不稳定的蛋白因子,该因子诱导周围正常SMCs去分化。